Spotlight: Jon Mills, M.B.A, Ph.D.

Maryann Zacharias Uncategorized

Jon Mills

Jon Mills, MBA, PHD

On June 2, 2016, Jon Mills, MBA, PhD, defended his dissertation titled, “Comparative Effectiveness of Dual-Action versus Single-Action Antidepressants for Treatment of People Diagnosed with Co-Occurring HIV/AIDS and a Major Depression: A Growing Syndemic,” a study that involved a collaboration with the CFAR Network of Integration Clinical Systems (CNICS) cohort study.

Dr. Mills was a doctoral student at SHARC. He completed his Masters in Business Administration at the University of Colorado and went on to pursue a PhD in Health Services Research as a student at the University of Florida.

Dr. Mills was an active student member of SHARC. He has attended all SHARC conferences and presented posters using SHARC data. He was the leader of the Medical Monitoring Project (MMP) working group and is the primary author on three abstracts and one manuscript using this data.

His most recent paper as a primary author is titled, “The comparative impact of different patient-centered medical home domains on satisfaction among individuals living with type II diabetes.” The study focused on diabetes, however, patient-centered medical homes (PCMHs) are a model of providing care that is quite applicable to people living with HIV/AIDS. Dr. Mills hopes to complete a study at some point in the future analyzing collaborative care models like PCMHs in a population with HIV/AIDS and depression.

When asked about his most significant accomplishments at SHARC, Dr. Mills stated,“The main accomplishment was taking advantage of an incredible opportunity to collaborate with an exceptional group of faculty, students and staff. I experienced first hand the importance of collaboration especially when addressing a health issue as complex as HIV/AIDS and the co-morbidities common among this population.  Our task is not a one person job.”

Regarding his future goals, Dr. Mills has expressed interest in pursuing a career in academia. He intends to continue his research studying the impact of interventions, policies, and treatment for people suffering from co-occurring psychiatric/substance use disorder and HIV/AIDS. He would also like to continue developing expertise in comparative effectiveness research (CER), stating, “I learned from my dissertation that CER is much more complex than meets the eye. I find CER to be an essential type of research in translational science especially in the absence of a paradigm shift in treatment (e.g. discovery of a cure of HIV/AIDS).